INCB062079
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INCB062079, covering 2025-10-21 to 2025-10-21. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies [Phase 1]